Basic Information
| LncRNA/CircRNA Name | RP11-445H22.4 |
| Synonyms | KCNK15-AS1 |
| Region | GRCh38_20:44694892-44746021 |
| Ensemble | ENSG00000244558 |
| Refseq | NR_132377 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | qPCR etc. |
| Sample | breast cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | In breast cancer patients, the expression level of lncRNA RP11-445H22.4 is significantly increased. Its expression levels were correlated with estrogen receptor (ER), progesterone receptor (PR), and menopausal status of the breast cancer patients. |
| Pubmed ID | 25929808 |
| Year | 2015 |
| Title | Clinical significance of high expression of circulating serum lncRNA RP11-445H22.4 in breast cancer patients: a Chinese population-based study. |
External Links
| Links for RP11-445H22.4 | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |